These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34447677)

  • 21. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
    World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
    Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis.
    Xin S; Zhan Q; Chen X; Xu J; Yu Y
    BMC Gastroenterol; 2020 Jun; 20(1):186. PubMed ID: 32532204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis.
    Guo Z; Li M; Han B; Qi X
    Dig Liver Dis; 2018 Nov; 50(11):1153-1162. PubMed ID: 30224316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
    Del Chierico F; Nobili V; Vernocchi P; Russo A; De Stefanis C; Gnani D; Furlanello C; Zandonà A; Paci P; Capuani G; Dallapiccola B; Miccheli A; Alisi A; Putignani L
    Hepatology; 2017 Feb; 65(2):451-464. PubMed ID: 27028797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
    Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK
    J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis.
    Shen C; Zhao CY; Wang W; Wang YD; Sun H; Cao W; Yu WY; Zhang L; Ji R; Li M; Gao J
    BMC Gastroenterol; 2014 Feb; 14():39. PubMed ID: 24559185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum homocysteine levels in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Patsiaoura K; Katsiki E; Zafeiriadou E; Deretzi G; Zavos C; Gavalas E; Katsinelos P; Mane V; Slavakis A
    Ann Hepatol; 2012; 11(1):68-76. PubMed ID: 22166563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Role of Neutrophil to Lymphocyte Ratio in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Shavakhi M; Nourigheimasi S; Dioso E; Goutnik M; Lucke-Wold B; Khanzadeh S; Heidari F
    Can J Gastroenterol Hepatol; 2022; 2022():1554079. PubMed ID: 37601979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating irisin in nonalcoholic fatty liver disease: an updated meta-analysis.
    Qiu S; Wang Q; Cai X; Sun Z; Wu T
    Endokrynol Pol; 2023; 74(1):47-54. PubMed ID: 36094873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
    BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels.
    Jiang LL; Li L; Hong XF; Li YM; Zhang BL
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):662-6. PubMed ID: 19282764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.
    Wang X; Li W; Zhang Y; Yang Y; Qin G
    Int J Clin Exp Med; 2015; 8(10):17221-34. PubMed ID: 26770315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between resistin and ghrelin levels with fibrosis in nonalcoholic fatty liver disease.
    Eminler AT; Aygun C; Konduk T; Kocaman O; Senturk O; Celebi A; Gurbuz Y; Hulagu S
    J Res Med Sci; 2014 Nov; 19(11):1058-61. PubMed ID: 25657751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.
    Alkhouri N; Johnson C; Adams L; Kitajima S; Tsuruno C; Colpitts TL; Hatcho K; Lawitz E; Lopez R; Feldstein AE
    PLoS One; 2018; 13(8):e0202226. PubMed ID: 30161179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.